BackProPhase Labs Overview

ProPhase Labs Total Current Liabilities

ProPhase Labs's total current liabilities is $58M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$58.09M
126.67% YoYΔ $32.46M vs prior year quarter

Peer trimmed avg / median

Loading

ProPhase Labs Total Current Liabilities History

Loading

ProPhase Labs vs. peers: Total Current Liabilities Comparison

Loading

ProPhase Labs Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ProPhase Labs (PRPH) FAQ

As of the most recent data (June 2026), PRPH shows a total current liabilities of $58M. That compares with $26M in the prior-year period — up 126.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PRPH's total current liabilities is now $58M (was $26M) — a 126.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ProPhase Labs is outperforming or lagging.

Tracking PRPH's total current liabilities over time shows whether ProPhase Labs is scaling, shrinking, or reshaping that part of the business. The current reading is $58M That compares with $26M in the prior-year period — up 126.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has ProPhase Labs's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $58M) with ownership activity and broader fundamentals.

ProPhase Labs's total current liabilities is $58M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.